|
| | CIS-TRIMETHOXY STILBENE Basic information |
| Product Name: | CIS-TRIMETHOXY STILBENE | | Synonyms: | 1,3-DIMETHOXY-5-[(1Z)-2-(4-METHOXYPHENYL)ETHENYL]-BENZENE;CIS-TRIMETHOXY STILBENE;CIS-TRISMETHOXY RESVERATROL;(Z)-3,5,4'-Trimethoxystilbene;1,2,3-trimethoxy-4-(2-phenylethenyl)benzene;1,3-dimethoxy-5-[(Z)-2-(4-methoxyphenyl)ethenyl]benzene;(Z)-1-(3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)ethene;Benzene, 1,3-dimethoxy-5-[(1Z)-2-(4-methoxyphenyl)ethenyl]- | | CAS: | 94608-23-8 | | MF: | C17H18O3 | | MW: | 270.32 | | EINECS: | | | Product Categories: | | | Mol File: | 94608-23-8.mol |  |
| | CIS-TRIMETHOXY STILBENE Chemical Properties |
| Melting point | 55-57 °C | | Boiling point | 423.8±35.0 °C(Predicted) | | density | 1.104±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | ≤50mg/ml in DMSO;50mg/ml in dimethyl formamide | | form | solution in ethanol. | | CAS DataBase Reference | 94608-23-8 |
| Hazard Codes | Xi | | Risk Statements | 41 | | Safety Statements | 26-39 |
| | CIS-TRIMETHOXY STILBENE Usage And Synthesis |
| Description | Resveratrol is a potent antioxidant found in grapes and red wine that also has anti-proliferative, anti-neoplastic and anti-angiogenic activities. In addition, resveratrol activates sirtuins and, in yeast, extends lifespan. cis-trismethoxy Resveratrol is a potent anti-mitotic drug that is 100-fold more active than resveratrol at inhibiting the growth of human colon cancer Caco-2 cells. It inhibits tubulin polymerization in a dose-dependent manner (IC50 = 4 μM) and inhibits enzymes involved in the synthesis of the polyamines, putrescine, and spermidine. trans-trismethoxy Resveratrol has superior pharmacokinetic characteristics when compared with resveratrol, including greater plasma exposure, longer elimination half-life, and lower clearance. | | Uses | Resveratrol is a potent antioxidant found in grapes and red wine that also has anti-proliferative, anti-neoplastic and anti-angiogenic activities. In addition, resveratrol activates sirtuins and, in yeast, extends lifespan. cis-trismethoxy Resveratrol is a potent anti-mitotic drug that is 100-fold more active than resveratrol at inhibiting the growth of human colon cancer Caco-2 cells. It inhibits tubulin polymerization in a dose-dependent manner (IC50 = 4 μM) and inhibits enzymes involved in the synthesis of the polyamines, putrescine, and spermidine. trans-trismethoxy Resveratrol has superior pharmacokinetic characteristics when compared with resveratrol, including greater plasma exposure, longer elimination half-life, and lower clearance. | | Uses | cis-trismethoxy Resveratrol is a potent antioxidant found in grapes and red wine. Also, it is a resveratrol analog with increased antiproliferative activity towards a number of cancer cell lines. | | in vitro | cis-trismethoxy resveratrol at 0.3 microm could exert a 80% growth inhibition of human colon cancer caco-2 cells and arrest growth completely at 0.4 microm. the cis conformation of cis-trismethoxy resveratrol was also 100-fold more potent than the trans isomer. cis-trismethoxy resveratrol was able to cause cell cycle arrest at the g2/m phase transition and inhibit tubulin polymerization dose-dependently, leading to the depletion of the polyamines, putrescine and spermidine. in addition, cis-trismethoxy resveratrol inhibited partially colchicine binding to its binding site on tubulin [1]. | | in vivo | previous study found that from the angle of pharmacokinetics, cis-trismethoxy resveratrol appeared to be a superior analog of resveratrol since it was orally available and showed greater plasma exposure, longer elimination half-life and lower clearance. due to the superior pharmacokinetic characteristics of cis-trismethoxy resveratrol had, its potentials as a preventive or therapeutic agent in resveratrol-effective diseases would be considered [2]. | | IC 50 | 4 microm for tubulin polymerization | | references | [1] schneider, y. ,chabert, p.,stutzmann, j., et al. resveratrol analog (z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. international journal of cancer 107, 189-196 (2003).
[2] lin, h. s. and ho, p.c. a rapid hplc method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (tms) in rat plasma and its application in pharmacokinetic study. journal of pharmaceutical & biomedical analysis 49, 387-392 (2009). |
| | CIS-TRIMETHOXY STILBENE Preparation Products And Raw materials |
|
